External Facilitation to Increase Prescribing of AUD Medications in the Psychiatric Setting

NCT ID: NCT07053098

Last Updated: 2025-07-08

Basic Information

• Recruitment Status: RECRUITING
• Clinical Phase: NA
• Total Enrollment: 40 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2025-03-18
• Study Completion Date: 2027-05-31

Brief Summary

This project will pilot test an implementation facilitation intervention to increase prescribing of medications for alcohol use disorder (MAUD) in patients with major mental illness and alcohol use disorder in three psychiatry treatment clinics.

Detailed Description

This project will pilot test an implementation facilitation intervention to increase prescribing of medications for alcohol use disorder (MAUD) in patients with major mental illness and alcohol use disorder in three psychiatry treatment clinics. Guided by the integrated Promoting Action on Research Implementation in Health Services framework, an external facilitator will work with each clinics' internal champion to (1) provide clinic level education on MAUD in non-specialty care settings, (2) provide clinic level training in using a standardized screen measure for alcohol use disorder, documenting screening results in the electronic health record, and documenting alcohol use disorder diagnosis in the electronic health record, (3) help internal champions use an audit and feedback system for weekly review of MAUD education and prescribing, (4) help internal champions do weekly care coordination for patients with major mental illness and alcohol use disorder, and (5) make educational materials on MAUD available on site to patients so they are informed about these treatment options. Internal champions and clinics will have access to consultation from a MAUD clinician expert. These activities will take place across pre-implementation and implementation phases and will be followed by a post-implementation facilitation sustainment period during which clinics and champions continue implementation on their own. Formative Evaluation activities will take place throughout; at the end of the sustainment phase, MAUD outcomes will be assessed.

Conditions

Alcohol-Related Disorders; Psychiatric Disorder

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: HEALTH_SERVICES_RESEARCH
• Blinding Strategy: NONE

Study Groups

Implementation Facilitation

This Implementation Facilitation Intervention will include external facilitation, staff training, patient education, audit and feedback, and care coordination.

Group Type: EXPERIMENTAL

Implementation Facilitation

Intervention Type: OTHER

Implementation facilitation is a multi-faceted process of enabling and supporting the adoption and integration of best practices into routine clinical care. It involves collaboration to understand a setting's challenges and barriers and working together to identify the best activities to address them. IF will incorporate External Facilitation, a problem-solving implementation strategy that builds supportive interpersonal relationships between an External Facilitator who is outside of the clinic who works with clinics and their identified internal champions to learn their unique barriers to implementation, use strategies to address these barriers, and plan for sustainability by integrating the practice into routine processes and workflows. Other implementation activities that will be used IF include staff training, patient education, audit and feedback, and care coordination.

Interventions

Implementation Facilitation

Implementation facilitation is a multi-faceted process of enabling and supporting the adoption and integration of best practices into routine clinical care. It involves collaboration to understand a setting's challenges and barriers and working together to identify the best activities to address them. IF will incorporate External Facilitation, a problem-solving implementation strategy that builds supportive interpersonal relationships between an External Facilitator who is outside of the clinic who works with clinics and their identified internal champions to learn their unique barriers to implementation, use strategies to address these barriers, and plan for sustainability by integrating the practice into routine processes and workflows. Other implementation activities that will be used IF include staff training, patient education, audit and feedback, and care coordination.

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• For prescribers: working as a prescriber, non-prescribing clinician, or administrator at one of the three participating clinics.
• For patients: has major mental illness (major depressive disorders, bipolar disorder, schizophrenia spectrum disorders, other psychotic disorders; posttraumatic stress disorder)
• For patients: has Alcohol Use Disorder and is being treated in one of the three participating clinics.

Exclusion Criteria

• For all: age is less than 18 years old
• For all: not able to complete informed consent

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 90 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

University of Maryland, Baltimore

OTHER

Sponsor Role: lead

Responsible Party

Melanie E Bennett

Professor

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Melanie Bennett

Role: PRINCIPAL_INVESTIGATOR

University of Maryland, Baltimore

Locations

University of Maryland Baltimore

Baltimore, Maryland, United States

Site Status: RECRUITING

Countries

United States

Central Contacts

Melanie Bennett, PhD

Role: CONTACT

mbennett@som.umaryland.edu

410-706-2490

Brian Brandler

Role: CONTACT

bbrandler@som.umaryland.edu

410-706-2490

Facility Contacts

Melanie Bennett

Role: primary

mbennett@som.umaryland.edu

410-706-0892

Brian Brandler

Role: backup

bbrandler@som.umaryland.edu

Other Identifiers

1R34AA032051-01

Identifier Type: NIH

Identifier Source: org_study_id

View Link